Physician profile
Michael Gold
NPI 1215151162
$4,854.12
in general payments reported to CMS, 2019-2025
7 companies · $4,634 in 2025
The $4,634 reported for 2025 was more than what 94% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.72 · 2021: $14.97 · 2022: $136 · 2023: $19.92 · 2024: $30.22 · 2025: $4,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Food and Beverage: $169 · Travel and Lodging: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Food and Beverage | $168.94 |
| Travel and Lodging | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,563.94 | 2020-2025 | |
| Acadia Pharmaceuticals INC | $77.70 | 2025 | Nuplazid |
| Boston Scientific Corporation | $68.12 | 2022 | |
| Allergan, INC. | $44.12 | 2022 | |
| Biosense Webster, INC. | $41.10 | 2025 | Carto 3 |
| Janssen Biotech, INC. | $34.89 | 2021-2023 | Tremfya |
| Novartis Pharmaceuticals Corporation | $24.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.